Piper Sandler reaffirmed its positive stance on Inspire Medical Systems (NYSE:NYSE:INSP), maintaining an Overweight rating with a $260.00 price target. The endorsement comes after a steep 14.15% ...

The global sleep apnea implants market is expected to grow from USD 317.1 million in 2023 to USD 1,158.1 million by 2033, at ...

They bring instant peace of mind to travelers of all ages. A former magazine editor and beauty eCommerce merchandiser, I've tried hundreds of products over the past ten-plus years. I've also ...

Charlie A. Hamm, MD, PhD, from Charité-Universitätsmedizin Berlin, and colleagues examined the feasibility and safety of a community-based MRI diagnostic strategy in men aged 18 to 75 years with ...

The Food and Drug Administration (FDA) on Dec. 20 approved the obesity medication Zepbound (tirzepatide) as the first pharmaceutical treatment for moderate-to-severe obstructive sleep apnea (OSA ...

Researchers at Charité – Universitätsmedizin Berlin conducted a study to determine whether this MRI-first approach is safe over the long term. Their findings show that this strategy poses no ...

Adv Neonatal Care. 2005;5(1):14-27. Staff members accompanying infants to the MRI suite are also screened for biomedical implants or metallic foreign bodies that might create a hazard in proximity ...

The U.S. Food and Drug Administration (FDA) has granted approval for Zepbound, a weight-loss medication, to treat moderate to severe obstructive sleep apnea (OSA) in individuals with obesity.

s proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology of its kind that provides a safe and effective treatment for moderate to severe ...

Nyxoah's Genio implant is poised to revolutionize Obstructive Sleep Apnea treatment ... and Inspire Medical Systems (INSP). - Inspire has developed a neurostimulation device approved by the ...

(Getty Images) (NewsNation) — Zepbound became the first drug approved by the Food and Drug Administration to treat obstructive sleep apnea in obese adults earlier this month. “This is a major step ...